glimepiride tablet
carlsbad technology, inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 2 mg - glimepiride tablet usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies ( 14.1) ]. limitations of use glimepiride should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets usp are contraindicated in patients with a history of a hypersensitivity reaction to: - glimepiride or any of the product's ingredients [ see warnings and precautions ( 5.2) ]. sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives. reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g. anaphylax
glimepiride 4mg tablets
somex pharma - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
bristol laboratories ltd - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
phoenix healthcare distribution ltd - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
accord-uk ltd - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
waymade healthcare plc - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
de pharmaceuticals - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
mawdsley-brooks & company ltd - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
actavis uk ltd - glimepiride - oral tablet - 4mg
glimepiride 4mg tablets
alliance healthcare (distribution) ltd - glimepiride - oral tablet - 4mg